source
- Majority rate home diagnostic tests ‘very helpful,’ but just 33% for accuracy: DNV surveyPeople are twice as likely to describe home diagnostic tests as very helpful versus them as very accurate, according to new global research from the quality assurance, risk management and certifica…Fierce Biotech · 17h ago↗ source
- GSK receives FDA accelerated approval for neladalkib (Nelkarmi) in ALK-positive lung cancer, second win from Nuvalent dealGSK announced that the FDA has granted accelerated approval to its tyrosine kinase inhibitor neladalkib, to be sold under the brand name Nelkarmi, for patients with ALK‑positive non‑small cell lung…